Nurix Therapeutics (NRIX) Asset Utilization Ratio (2020 - 2026)

Nurix Therapeutics (NRIX) has 7 years of Asset Utilization Ratio data on file, last reported at 0.06 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.06, down 26.55% year-over-year; the trailing twelve-month figure through Feb 2026 was 0.06 (down 26.55% YoY), and the FY2025 annual result was 0.12, up 16.24% from the prior year.
• Asset Utilization Ratio declined to 0.06 in Q1 2026 per NRIX's latest filing, from 0.09 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.24 in Q1 2024 and troughed at 0.06 in Q1 2026.
• A 5-year average of 0.12 and a median of 0.1 in 2025 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio jumped 163.05% in 2023, then sank 63.71% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.09 in 2022, then jumped by 163.05% to 0.23 in 2023, then sank by 60.24% to 0.09 in 2024, then retreated by 1.61% to 0.09 in 2025, then fell by 28.89% to 0.06 in 2026.
• Business Quant data shows NRIX's Asset Utilization Ratio at 0.06 in Q1 2026, 0.09 in Q4 2025, and 0.1 in Q3 2025.